Germany's biopharmaceutical sector ranks fourth globally with 650+ biotech companies, driven by strong industry-research-government collaboration and bioregions. The sector experiences 8% annual prescription growth due to increasing chronic diseases and an aging population, with companies like Calidi Biotherapeutics, Eleva Biologics, and Roche benefiting from Germany's strategic advantages. #BMG2025, dedicated to propelling bioprocessing innovation and market expansion, will address these developments.
Featuring industry leaders like Uwe Gottschalk, event chairman, and representatives from Sanofi, Abbvie, and Roche, while offering 120+ networking opportunities and expert sessions on bioprocessing, CMC strategy, and facility design, focusing on critical issues such as risk mitigation, regulatory compliance, automation, AI, and sustainability in the evolving biologics manufacturing landscape.